Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Knome's KnoSys

Premium

Knome has launched version 3 of its KnoSys Informatics and Genomic Interpretation System. The upgraded version includes in silico panels, improved database server functionality, a new interface, a more open architecture, new reference data sources, performance improvements, integration with IGV, and reading of gVCF files.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.